173 related articles for article (PubMed ID: 37738592)
21. Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases.
Dalal RS; Palchaudhuri S; Snider CK; Lewis JD; Mehta SJ; Lichtenstein GR
Inflamm Bowel Dis; 2021 Mar; 27(4):500-506. PubMed ID: 32440693
[TBL] [Abstract][Full Text] [Related]
22. Cannabis finds its way into treatment of Crohn's disease.
Schicho R; Storr M
Pharmacology; 2014; 93(1-2):1-3. PubMed ID: 24356243
[TBL] [Abstract][Full Text] [Related]
23. Role of cannabis in digestive disorders.
Goyal H; Singla U; Gupta U; May E
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):135-143. PubMed ID: 27792038
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation.
Nayak AP; Loblundo C; Bielory L
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):449-457. PubMed ID: 36280137
[TBL] [Abstract][Full Text] [Related]
25. [Cannabis use among patients with inflammatory bowel disease].
Xantus G; Gyarmathy VA
Orv Hetil; 2021 Mar; 162(12):443-448. PubMed ID: 33764022
[TBL] [Abstract][Full Text] [Related]
26. Cannabis for Inflammatory Bowel Diseases: Should We Follow the Wisdom of the Crowd?
Naftali T
Isr Med Assoc J; 2019 Nov; 21(11):756-758. PubMed ID: 31713366
[No Abstract] [Full Text] [Related]
27. Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization?
Naftali T; Konikoff FM
Isr Med Assoc J; 2017 Feb; 19(2):95-97. PubMed ID: 28457058
[No Abstract] [Full Text] [Related]
28. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.
Maselli DB; Camilleri M
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1748-1758.e2. PubMed ID: 32673642
[TBL] [Abstract][Full Text] [Related]
29. Cannabis use disorders may protect against certain disorders of the digestive organs in people with schizophrenia but not in healthy controls.
Olesen JA; Posselt CM; Poulsen CH; Nordentoft M; Hjorthøj C
Psychol Med; 2020 Feb; 50(3):499-506. PubMed ID: 30880659
[TBL] [Abstract][Full Text] [Related]
30. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
Naftali T; Bar-Lev Schleider L; Dotan I; Lansky EP; Sklerovsky Benjaminov F; Konikoff FM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1276-1280.e1. PubMed ID: 23648372
[TBL] [Abstract][Full Text] [Related]
31. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
Gotfried J; Naftali T; Schey R
Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
[TBL] [Abstract][Full Text] [Related]
32. Non-Intoxicating Cannabinoids in Visceral Pain.
Svendsen K; Sharkey KA; Altier C
Cannabis Cannabinoid Res; 2024 Feb; 9(1):3-11. PubMed ID: 37883662
[TBL] [Abstract][Full Text] [Related]
33. Cannabis and Cannabinoids on Treatment of Inflammation: A Patent Review.
Nascimento Menezes PM; Valença Pereira EC; Gomes da Cruz Silva ME; da Silva BAO; de Souza Duarte Filho LAM; de Lima Araújo TC; Bezerra Lima KS; Silva FS; Rolim LA
Recent Pat Biotechnol; 2019; 13(4):256-267. PubMed ID: 31237222
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes.
Blevins LK; Bach AP; Crawford RB; Zhou J; Henriquez JE; Rizzo MD; Sermet S; Khan DMIO; Turner H; Small-Howard AL; Kaminski NE
Food Chem Toxicol; 2022 Dec; 170():113458. PubMed ID: 36228902
[TBL] [Abstract][Full Text] [Related]
35. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
36. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
Swaminath A; Berlin EP; Cheifetz A; Hoffenberg E; Kinnucan J; Wingate L; Buchanan S; Zmeter N; Rubin DT
Inflamm Bowel Dis; 2019 Feb; 25(3):427-435. PubMed ID: 30358848
[TBL] [Abstract][Full Text] [Related]
37. Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
Naftali T; Bar-Lev Schleider L; Sklerovsky Benjaminov F; Lish I; Konikoff FM; Ringel Y
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1376-1381. PubMed ID: 31567639
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
Ahmed W; Katz S
Gastroenterol Hepatol (N Y); 2016 Nov; 12(11):668-679. PubMed ID: 28035196
[TBL] [Abstract][Full Text] [Related]
39. Weeding out new drugs.
Ewan S
Drug Discov Today; 2005 Oct; 10(20):1336-7. PubMed ID: 16253865
[No Abstract] [Full Text] [Related]
40. Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects.
Nasser Y; Woo M; Andrews CN
Curr Treat Options Gastroenterol; 2020; 18(4):519-530. PubMed ID: 33250629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
